FDA Office of Special Health Issues

<

×

>

hide

You are viewing a Web site, archived on 11:28:53 Oct 18, 2004. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.


FDA Home Page \| Search FDA Site \| FDA A-Z Index \| Contact FDA

Information for Patients FDA's Office of Special Health Issues

		OSHI Mission The Office of Special Health Issues (OSHI) answers questions about FDA's activities related to HIV/AIDS, cancer, and other special health issues. The staff works with patients and their advocates to encourage and support participation in forming FDA regulatory policy. The staff also provides information about the FDA drug approval process and clinical trials. Mission Statement. Frequently Asked Questions				HIV and AIDS Activities Current information on AIDS therapies, clinical trials, and HIV testing. Cancer Liaison Program Information about and for cancer patient advocates and representatives. Diabetes Information designed to help people with diabetes manage their condition and live a healthy life. Clinical Trials General information about research trials that use human subjects, and links to clinical trials databases. Patient Representative Program How to share information about serious diseases with FDA advisory committees. Patient Involvement General information about life-threatening diseases, advisory committees, and clinical trials.			In the News FDA Seeks Oncology Drug Products Director Sculptra for facial wasting in HIV patients Two new fixed-dose combination drug products for HIV-1 Aldara approved for skin cancer New software helps detect lung nodules FDA HIV/AIDS E-mail List Contact Us Related Websites Oncology Tools AIDSinfo ClinicalTrials.gov MEDLINEplus

FDA Home Page \| Search FDA Site \| FDA A-Z Index \| Contact FDA \| Privacy \| Accessibility FDA Office of Special Health Issues